2009
DOI: 10.1016/j.gie.2009.01.026
|View full text |Cite
|
Sign up to set email alerts
|

Placement of Polyflex stents in patients with locally advanced esophageal cancer is safe and improves dysphagia during neoadjuvant therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
37
2
2

Year Published

2009
2009
2022
2022

Publication Types

Select...
5
3
2

Relationship

1
9

Authors

Journals

citations
Cited by 63 publications
(43 citation statements)
references
References 24 publications
2
37
2
2
Order By: Relevance
“…Migration rates range from 13% to 29% in randomized studies comparing SEPSs with selfexpanding metal stents (SEMSs) in patients with unresectable esophageal cancer. 5,6 In the current study by Adler et al, 1 6 of 13 stents (46%) migrated at some point. As the authors already mentioned, some of the migrations were likely a sign of response to neoadjuvant therapy.…”
supporting
confidence: 45%
“…Migration rates range from 13% to 29% in randomized studies comparing SEPSs with selfexpanding metal stents (SEMSs) in patients with unresectable esophageal cancer. 5,6 In the current study by Adler et al, 1 6 of 13 stents (46%) migrated at some point. As the authors already mentioned, some of the migrations were likely a sign of response to neoadjuvant therapy.…”
supporting
confidence: 45%
“…Preoperative esophageal stenting before neoadjuvant therapy is a concept that currently is being evaluated as a modality to relieve dysphagia and maximize nutritional supplementation before surgical resection. [7][8][9][10] We have previously reported that the removable selfexpandable plastic stent (SEPS) is effective in relieving dysphagia and allows for oral feeding in patients with locally advanced esophageal cancer undergoing neoadjuvant therapy before surgery. However, plastic stents are technically difficult to deploy and have a high migration rate.…”
mentioning
confidence: 99%
“…The use of esophageal stents in patients receiving neoadjuvant therapy before surgery have been studied but is still debated because the treatment of dysphagia is not always sufficient to improve the nutritional status of the patients and is associated with non-negligible morbidity [10]. Since the 1990s, esophageal intubation with stents has gradually developed with high rates of complete closure of tracheo/broncho-esophageal fistula and improvement in symptoms of respiratory tract and quality of life [11][12][13].…”
Section: Malignant Stricturesmentioning
confidence: 99%